Corporate News Report
Xiamen Amoytop Biotech Co Ltd. (688278.SS) closed unchanged at 0 % during the 24‑hour trading window that ended at 02:12 AM Central European Time on Saturday, 24 th. The share is presently priced at approximately CNY 43.77 on the main exchanges.
Market Overview
- Market Capitalisation: CNY 18.6 billion.
- Total Outstanding Shares: 411.6 million.
- Volume Traded in the Last 24 Hours: CNY 108.9 million.
- Year‑to‑Date Performance: Down 14.93 % since the previous month’s close.
- 200‑Day Simple Moving Average: CNY 55.57.
- 52‑Week Range: Highest price of CNY 85.57 on 19 Dec 2025; lowest price of CNY 44.98 on 22 Oct 2026.
These figures suggest that the company’s share price remains within a relatively narrow band around its 200‑day average, while experiencing a notable decline in recent months.
Comparative Peer Performance
| Stock | Ticker | 24‑Hour Change | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| China Resources Cloud | 1766.HK | –0.85 % | HKD 5.25 | HKD 25.9 bn | 9.25 |
| Guangdong Electric Power Development | 000539.SZ | 0 % | CNY 4.98 | CNY 24 bn | 1,610 |
| Inner Mongolia Yili Industries | 600887.SS | 0 % | CNY 28.19 | CNY 24.1 bn | 17.24 |
| Haier Smart Home | 6690.HK | –1.4 % | HKD 19.41 | HKD 25.9 bn | 7.80 |
| Lepu Medical | 300003.SZ | 0 % | CNY 12.29 | CNY 22 bn | 28.77 |
While Xiamen Amoytop Biotech’s share price remained flat, peers displayed a mix of modest declines and stability. Of particular note is the exceptionally high price‑to‑earnings ratio of Guangdong Electric Power Development, which may indicate a valuation outlier in its sector.
Company Profile
Xiamen Amoytop Biotech Co Ltd. is a Chinese biotechnology enterprise headquartered in Xiamen. The company is listed on the Shanghai Stock Exchange and focuses on the research, development, and commercialization of biopharmaceutical products. Its operations encompass a range of therapeutic areas, with a pipeline that includes both novel biologics and targeted therapies.
This report provides a concise snapshot of Xiamen Amoytop Biotech’s recent trading activity and situates it within the broader context of related equities. The data reflect current market conditions as of the stated reporting period.